#news #biotech Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs .Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs
ntaylor
Thu, 03/25/2021 – 08:40

from FierceBiotech: Biotech https://ift.tt/31lwzOQ